Gravitate Health FHIR Implementation Guide (FHIR R4)
0.1.0 - CI Build
Gravitate Health FHIR Implementation Guide (FHIR R4)
0.1.0 - CI Build
Gravitate Health FHIR Implementation Guide (FHIR R4), published by . This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/hl7-eu/gravitate-health-ips/ and changes regularly. See the Directory of published versions
{
"resourceType" : "Bundle",
"id" : "gravitate-Pedro",
"meta" : {
"profile" : [
🔗 "http://hl7.org/fhir/uv/ips/StructureDefinition/Bundle-uv-ips"
]
},
"identifier" : {
"system" : "https://www.gravitatehealth.eu/sid/doc",
"value" : "Pedro-ips-1"
},
"type" : "document",
"timestamp" : "2021-04-18T09:22:00+02:00",
"entry" : [
{
"fullUrl" : "https://myserver.org/Composition/5702fd1d-dd26-402e-a7c0-7629a5d9bba1",
"resource" : {
"resourceType" : "Composition",
"id" : "gravitate-Pedro",
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><b>Id:</b> gravitate-Pedro<br/><b>status:</b> final<br/><b>Type:</b> Patient summary Document<br/><b>Subject:</b> Pedro Gravitate<br/><b>Sections:</b><br/><ul><li><b>Title:</b> Problem List<br/><b>Code:</b> Problem list Reported (11450-4)</li><br/><ul><li><b>Entry:</b> <a href=\"Condition-pedro-cond-1.html\">HIV</a></li><br/><li><b>Entry:</b> <a href=\"Condition-pedro-cond-2.html\">Depression</a></li><br/><li><b>Entry:</b> <a href=\"Condition-pedro-cond-3.html\">IBS</a></li><br/></ul><li><b>Title:</b> Medication Summary<br/><b>Code:</b> Hx of Medication use (10160-0)</li><br/><ul><li><b>Entry:</b> <a href=\"MedicationStatement-pedro-med-stat-1.html\">Dovato lamivudine and dolutegravir, 300 mg/50 mg</a></li><br/><li><b>Entry:</b> <a href=\"MedicationStatement-pedro-med-stat-2.html\">Mirtazapine 15 mg</a></li><br/><li><b>Entry:</b> <a href=\"MedicationStatement-pedro-med-stat-3.html\">Calcium carbonate 500 mg</a></li><br/><li><b>Entry:</b> <a href=\"MedicationStatement-pedro-med-stat-4.html\">Cinitrapide 1 mg</a></li><br/><li><b>Entry:</b> <a href=\"MedicationStatement-pedro-med-stat-5.html\">Collagen and magnesium supplements</a></li><br/><li><b>Entry:</b> <a href=\"MedicationStatement-pedro-med-stat-6.html\">Vitamin C supplements</a></li><br/><li><b>Entry:</b> <a href=\"MedicationStatement-pedro-med-stat-7.html\">Protein supplements</a></li><br/></ul></ul></div>"
},
"status" : "final",
"type" : {
"coding" : [
{
"system" : "http://loinc.org",
"code" : "60591-5",
"display" : "Patient summary Document"
}
]
},
"subject" : {
"reference" : "Patient/pedro-patient",
"display" : "Pedro Gravitate"
},
"date" : "2018-07-10T15:22:00+02:00",
"author" : [
{
"reference" : "Practitioner/pedro-pract",
"display" : "Dr. Anna Karlsson"
}
],
"title" : "Patient Summary (Pedro Gravitate)",
"confidentiality" : "N",
"section" : [
{
"title" : "Problem List",
"code" : {
"coding" : [
{
"system" : "http://loinc.org",
"code" : "11450-4",
"display" : "Problem list Reported"
}
]
},
"entry" : [
{
"reference" : "Condition/pedro-cond-1",
"display" : "Depression"
},
{
"reference" : "Condition/pedro-cond-2",
"display" : "HIV"
},
{
"reference" : "Condition/pedro-cond-3",
"display" : "IBS"
}
]
},
{
"title" : "Medication Summary",
"code" : {
"coding" : [
{
"system" : "http://loinc.org",
"code" : "10160-0",
"display" : "Hx of Medication use"
}
]
},
"entry" : [
{
"reference" : "MedicationStatement/pedro-med-stat-1",
"display" : "Dovato lamivudine and dolutegravir, 300 mg/50 mg"
},
{
"reference" : "MedicationStatement/pedro-med-stat-2",
"display" : "Mirtazapine 15 mg"
},
{
"reference" : "MedicationStatement/pedro-med-stat-3",
"display" : "Calcium carbonate 500 mg"
},
{
"reference" : "MedicationStatement/pedro-med-stat-4",
"display" : "Cinitrapide 1 mg"
},
{
"reference" : "MedicationStatement/pedro-med-stat-5",
"display" : "Collagen and magnesium supplements"
},
{
"reference" : "MedicationStatement/pedro-med-stat-6",
"display" : "Vitamin C supplements"
},
{
"reference" : "MedicationStatement/pedro-med-stat-7",
"display" : "Protein supplements"
}
]
}
]
}
},
{
"fullUrl" : "https://myserver.org/Patient/pedro-patient",
"resource" : {
"resourceType" : "Patient",
"id" : "pedro-patient",
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">Age: 42 years. I live alone, single. Electronics store salesperson Smoker since the age of 20 Interests: cultural events and concerts. I enjoy mountain activities, skiing in winter and hiking the rest of the year. Health Conditions HIV (diagnosed with 38 years) Depression</div>"
},
"extension" : [
{
"extension" : [
{
"url" : "code",
"valueCodeableConcept" : {
"coding" : [
{
"system" : "urn:iso:std:iso:3166",
"code" : "ES",
"display" : "Spain"
}
]
}
}
],
"url" : "http://hl7.org/fhir/StructureDefinition/patient-citizenship"
}
],
"identifier" : [
{
"system" : "https://www.gravitatehealth.eu/sid/doc",
"value" : "Pedro-1"
},
{
"system" : "keycloak-id",
"value" : "b17f0a96-cb4a-45cd-be09-cbadbe428948"
}
],
"active" : true,
"name" : [
{
"family" : "Gravitate",
"given" : [
"Pedro"
]
}
],
"gender" : "male",
"birthDate" : "1980-10-05"
}
},
{
"fullUrl" : "https://myserver.org/Practitioner/pedro-pract",
"resource" : {
"resourceType" : "Practitioner",
"id" : "pedro-pract",
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><a name=\"Practitioner_pedro-pract\"> </a><p><b>Generated Narrative: Practitioner</b><a name=\"pedro-pract\"> </a><a name=\"hcpedro-pract\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">ResourcePractitioner "pedro-pract" </p></div><p><b>name</b>: Xavier García </p></div>"
},
"name" : [
{
"family" : "García",
"given" : [
"Xavier"
],
"prefix" : [
"Dr."
]
}
]
}
},
{
"fullUrl" : "https://myserver.org/Condition/pedro-cond-1",
"resource" : {
"resourceType" : "Condition",
"id" : "pedro-cond-1",
"meta" : {
"profile" : [
🔗 "http://hl7.org/fhir/uv/ips/StructureDefinition/Condition-uv-ips"
]
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><a name=\"Condition_pedro-cond-1\"> </a><p><b>Generated Narrative: Condition</b><a name=\"pedro-cond-1\"> </a><a name=\"hcpedro-cond-1\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">ResourceCondition "pedro-cond-1" </p><p style=\"margin-bottom: 0px\">Profile: <a href=\"https://build.fhir.org/ig/HL7/fhir-ips/StructureDefinition-Condition-uv-ips.html\">Condition (IPS)</a></p></div><p><b>clinicalStatus</b>: Active <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://terminology.hl7.org/5.5.0/CodeSystem-condition-clinical.html\">Condition Clinical Status Codes</a>#active)</span></p><p><b>verificationStatus</b>: confirmed <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> ([not stated]#confirmed)</span></p><p><b>code</b>: Depressive disorder (disorder) <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"https://browser.ihtsdotools.org/\">SNOWMED CT</a>#35489007)</span></p><p><b>subject</b>: See on this page: Patient/pedro-patient: Pedro Gravitate</p></div>"
},
"clinicalStatus" : {
"coding" : [
{
"system" : "http://terminology.hl7.org/CodeSystem/condition-clinical",
"code" : "active"
}
]
},
"verificationStatus" : {
"coding" : [
{
"code" : "confirmed"
}
]
},
"code" : {
"coding" : [
{
"system" : "http://snomed.info/sct",
"code" : "35489007",
"display" : "Depressive disorder (disorder)"
}
],
"text" : "Depressive disorder (disorder)"
},
"subject" : {
"reference" : "Patient/pedro-patient",
"display" : "Pedro Gravitate"
}
}
},
{
"fullUrl" : "https://myserver.org/Condition/pedro-cond-2",
"resource" : {
"resourceType" : "Condition",
"id" : "pedro-cond-2",
"meta" : {
"profile" : [
🔗 "http://hl7.org/fhir/uv/ips/StructureDefinition/Condition-uv-ips"
]
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><a name=\"Condition_pedro-cond-2\"> </a><p><b>Generated Narrative: Condition</b><a name=\"pedro-cond-2\"> </a><a name=\"hcpedro-cond-2\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">ResourceCondition "pedro-cond-2" </p><p style=\"margin-bottom: 0px\">Profile: <a href=\"https://build.fhir.org/ig/HL7/fhir-ips/StructureDefinition-Condition-uv-ips.html\">Condition (IPS)</a></p></div><p><b>clinicalStatus</b>: Active <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://terminology.hl7.org/5.5.0/CodeSystem-condition-clinical.html\">Condition Clinical Status Codes</a>#active)</span></p><p><b>verificationStatus</b>: confirmed <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> ([not stated]#confirmed)</span></p><p><b>code</b>: Human immunodeficiency virus infection <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"https://browser.ihtsdotools.org/\">SNOWMED CT</a>#86406008)</span></p><p><b>subject</b>: See on this page: Patient/pedro-patient: Pedro Gravitate</p><p><b>onset</b>: 2018</p><p><b>asserter</b>: See on this page: Practitioner/pedro-pract: Dr. Xavier García</p></div>"
},
"clinicalStatus" : {
"coding" : [
{
"system" : "http://terminology.hl7.org/CodeSystem/condition-clinical",
"code" : "active"
}
]
},
"verificationStatus" : {
"coding" : [
{
"code" : "confirmed"
}
]
},
"code" : {
"coding" : [
{
"system" : "http://snomed.info/sct",
"code" : "86406008",
"display" : "Human immunodeficiency virus infection"
}
],
"text" : "Human immunodeficiency virus infection"
},
"subject" : {
"reference" : "Patient/pedro-patient",
"display" : "Pedro Gravitate"
},
"onsetDateTime" : "2018",
"asserter" : {
"reference" : "Practitioner/pedro-pract",
"display" : "Dr. Xavier García"
}
}
},
{
"fullUrl" : "https://myserver.org/Condition/pedro-cond-3",
"resource" : {
"resourceType" : "Condition",
"id" : "pedro-cond-3",
"meta" : {
"profile" : [
🔗 "http://hl7.org/fhir/uv/ips/StructureDefinition/Condition-uv-ips"
]
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><a name=\"Condition_pedro-cond-3\"> </a><p><b>Generated Narrative: Condition</b><a name=\"pedro-cond-3\"> </a><a name=\"hcpedro-cond-3\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">ResourceCondition "pedro-cond-3" </p><p style=\"margin-bottom: 0px\">Profile: <a href=\"https://build.fhir.org/ig/HL7/fhir-ips/StructureDefinition-Condition-uv-ips.html\">Condition (IPS)</a></p></div><p><b>clinicalStatus</b>: Active <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://terminology.hl7.org/5.5.0/CodeSystem-condition-clinical.html\">Condition Clinical Status Codes</a>#active)</span></p><p><b>verificationStatus</b>: confirmed <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> ([not stated]#confirmed)</span></p><p><b>code</b>: Irritable bowel syndrome <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"https://browser.ihtsdotools.org/\">SNOWMED CT</a>#10743008)</span></p><p><b>subject</b>: See on this page: Patient/pedro-patient: Pedro Gravitate</p></div>"
},
"clinicalStatus" : {
"coding" : [
{
"system" : "http://terminology.hl7.org/CodeSystem/condition-clinical",
"code" : "active"
}
]
},
"verificationStatus" : {
"coding" : [
{
"code" : "confirmed"
}
]
},
"code" : {
"coding" : [
{
"system" : "http://snomed.info/sct",
"code" : "10743008",
"display" : "Irritable bowel syndrome"
}
],
"text" : "Irritable bowel syndrome"
},
"subject" : {
"reference" : "Patient/pedro-patient",
"display" : "Pedro Gravitate"
}
}
},
{
"fullUrl" : "https://myserver.org/MedicationStatement/pedro-med-stat-1",
"resource" : {
"resourceType" : "MedicationStatement",
"id" : "pedro-med-stat-1",
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><a name=\"MedicationStatement_pedro-med-stat-1\"> </a><p><b>Generated Narrative: MedicationStatement</b><a name=\"pedro-med-stat-1\"> </a><a name=\"hcpedro-med-stat-1\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">ResourceMedicationStatement "pedro-med-stat-1" </p></div><p><b>status</b>: active</p><p><b>medication</b>: See on this page: Medication/9d7be868-8264-4d94-ad04-ef04ecc92e52: Dovato 50 mg/300 mg (Dolutegravir/ Lamivudine) tablets</p><p><b>subject</b>: See on this page: Patient/pedro-patient: Pedro Gravitate</p><h3>Dosages</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Route</b></td></tr><tr><td style=\"display: none\">*</td><td>Oral use <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (standardterms.edqm.eu#20053000)</span></td></tr></table></div>"
},
"status" : "active",
"medicationReference" : {
"reference" : "Medication/9d7be868-8264-4d94-ad04-ef04ecc92e52",
"display" : "Dovato 50 mg/300 mg (Dolutegravir/ Lamivudine) tablets"
},
"subject" : {
"reference" : "Patient/pedro-patient",
"display" : "Pedro Gravitate"
},
"dosage" : [
{
"route" : {
"coding" : [
{
"system" : "http://standardterms.edqm.eu",
"code" : "20053000",
"display" : "Oral use"
}
]
}
}
]
}
},
{
"fullUrl" : "https://myserver.org/MedicationStatement/pedro-med-stat-2",
"resource" : {
"resourceType" : "MedicationStatement",
"id" : "pedro-med-stat-2",
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><a name=\"MedicationStatement_pedro-med-stat-2\"> </a><p><b>Generated Narrative: MedicationStatement</b><a name=\"pedro-med-stat-2\"> </a><a name=\"hcpedro-med-stat-2\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">ResourceMedicationStatement "pedro-med-stat-2" </p></div><p><b>status</b>: active</p><p><b>medication</b>: See on this page: Medication/fdb5c97f-0a46-41ba-bc34-2efd2ef2f7e4: Mirtazapine 30 mg Coated Tablet</p><p><b>subject</b>: See on this page: Patient/pedro-patient: Pedro Gravitate</p><h3>Dosages</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Route</b></td></tr><tr><td style=\"display: none\">*</td><td>Oral use <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (standardterms.edqm.eu#20053000)</span></td></tr></table></div>"
},
"status" : "active",
"medicationReference" : {
"reference" : "Medication/fdb5c97f-0a46-41ba-bc34-2efd2ef2f7e4",
"display" : "Mirtazapine 30 mg Coated Tablet"
},
"subject" : {
"reference" : "Patient/pedro-patient",
"display" : "Pedro Gravitate"
},
"dosage" : [
{
"route" : {
"coding" : [
{
"system" : "http://standardterms.edqm.eu",
"code" : "20053000",
"display" : "Oral use"
}
]
}
}
]
}
},
{
"fullUrl" : "https://myserver.org/MedicationStatement/pedro-med-stat-3",
"resource" : {
"resourceType" : "MedicationStatement",
"id" : "pedro-med-stat-3",
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><a name=\"MedicationStatement_pedro-med-stat-3\"> </a><p><b>Generated Narrative: MedicationStatement</b><a name=\"pedro-med-stat-3\"> </a><a name=\"hcpedro-med-stat-3\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">ResourceMedicationStatement "pedro-med-stat-3" </p></div><p><b>status</b>: active</p><p><b>medication</b>: See on this page: Medication/6f4151e9-91f6-4f1e-adc3-fb94dda7785g: CALCIO/VITAMINA D3 ROVI 1000 mg/880 UI COMPRIMIDOS EFERVESCENTES</p><p><b>subject</b>: See on this page: Patient/pedro-patient: Pedro Gravitate</p><h3>Dosages</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Route</b></td></tr><tr><td style=\"display: none\">*</td><td>Oral use <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (standardterms.edqm.eu#20053000)</span></td></tr></table></div>"
},
"status" : "active",
"medicationReference" : {
"reference" : "Medication/6f4151e9-91f6-4f1e-adc3-fb94dda7785g",
"display" : "CALCIO/VITAMINA D3 ROVI 1000 mg/880 UI COMPRIMIDOS EFERVESCENTES"
},
"subject" : {
"reference" : "Patient/pedro-patient",
"display" : "Pedro Gravitate"
},
"dosage" : [
{
"route" : {
"coding" : [
{
"system" : "http://standardterms.edqm.eu",
"code" : "20053000",
"display" : "Oral use"
}
]
}
}
]
}
},
{
"fullUrl" : "https://myserver.org/MedicationStatement/pedro-med-stat-4",
"resource" : {
"resourceType" : "MedicationStatement",
"id" : "pedro-med-stat-4",
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><a name=\"MedicationStatement_pedro-med-stat-4\"> </a><p><b>Generated Narrative: MedicationStatement</b><a name=\"pedro-med-stat-4\"> </a><a name=\"hcpedro-med-stat-4\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">ResourceMedicationStatement "pedro-med-stat-4" </p></div><p><b>status</b>: active</p><p><b>medication</b>: See on this page: Medication/6f4151e9-91f6-4f1e-adc3-fb94dda77854: cinitrapide 1 mg</p><p><b>subject</b>: See on this page: Patient/pedro-patient: Pedro Gravitate</p><h3>Dosages</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Route</b></td></tr><tr><td style=\"display: none\">*</td><td>Oral use <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (standardterms.edqm.eu#20053000)</span></td></tr></table></div>"
},
"status" : "active",
"medicationReference" : {
"reference" : "Medication/6f4151e9-91f6-4f1e-adc3-fb94dda77854",
"display" : "cinitrapide 1 mg"
},
"subject" : {
"reference" : "Patient/pedro-patient",
"display" : "Pedro Gravitate"
},
"dosage" : [
{
"route" : {
"coding" : [
{
"system" : "http://standardterms.edqm.eu",
"code" : "20053000",
"display" : "Oral use"
}
]
}
}
]
}
},
{
"fullUrl" : "https://myserver.org/MedicationStatement/pedro-med-stat-5",
"resource" : {
"resourceType" : "MedicationStatement",
"id" : "pedro-med-stat-5",
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><a name=\"MedicationStatement_pedro-med-stat-5\"> </a><p><b>Generated Narrative: MedicationStatement</b><a name=\"pedro-med-stat-5\"> </a><a name=\"hcpedro-med-stat-5\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">ResourceMedicationStatement "pedro-med-stat-5" </p></div><p><b>status</b>: active</p><p><b>medication</b>: See on this page: Medication/6f4151e9-91f6-4f1e-adc3-fb94dda77855: Collagen and magnesium supplements</p><p><b>subject</b>: See on this page: Patient/pedro-patient: Pedro Gravitate</p><h3>Dosages</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Route</b></td></tr><tr><td style=\"display: none\">*</td><td>Oral use <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (standardterms.edqm.eu#20053000)</span></td></tr></table></div>"
},
"status" : "active",
"medicationReference" : {
"reference" : "Medication/6f4151e9-91f6-4f1e-adc3-fb94dda77855",
"display" : "Collagen and magnesium supplements"
},
"subject" : {
"reference" : "Patient/pedro-patient",
"display" : "Pedro Gravitate"
},
"dosage" : [
{
"route" : {
"coding" : [
{
"system" : "http://standardterms.edqm.eu",
"code" : "20053000",
"display" : "Oral use"
}
]
}
}
]
}
},
{
"fullUrl" : "https://myserver.org/MedicationStatement/pedro-med-stat-6",
"resource" : {
"resourceType" : "MedicationStatement",
"id" : "pedro-med-stat-6",
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><a name=\"MedicationStatement_pedro-med-stat-6\"> </a><p><b>Generated Narrative: MedicationStatement</b><a name=\"pedro-med-stat-6\"> </a><a name=\"hcpedro-med-stat-6\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">ResourceMedicationStatement "pedro-med-stat-6" </p></div><p><b>status</b>: active</p><p><b>medication</b>: See on this page: Medication/6f4151e9-91f6-4f1e-adc3-fb94dda77856: Vitaminc C supplement</p><p><b>subject</b>: See on this page: Patient/pedro-patient: Pedro Gravitate</p><h3>Dosages</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Route</b></td></tr><tr><td style=\"display: none\">*</td><td>Oral use <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (standardterms.edqm.eu#20053000)</span></td></tr></table></div>"
},
"status" : "active",
"medicationReference" : {
"reference" : "Medication/6f4151e9-91f6-4f1e-adc3-fb94dda77856",
"display" : "Vitaminc C supplement"
},
"subject" : {
"reference" : "Patient/pedro-patient",
"display" : "Pedro Gravitate"
},
"dosage" : [
{
"route" : {
"coding" : [
{
"system" : "http://standardterms.edqm.eu",
"code" : "20053000",
"display" : "Oral use"
}
]
}
}
]
}
},
{
"fullUrl" : "https://myserver.org/MedicationStatement/pedro-med-stat-7",
"resource" : {
"resourceType" : "MedicationStatement",
"id" : "pedro-med-stat-7",
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><a name=\"MedicationStatement_pedro-med-stat-7\"> </a><p><b>Generated Narrative: MedicationStatement</b><a name=\"pedro-med-stat-7\"> </a><a name=\"hcpedro-med-stat-7\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">ResourceMedicationStatement "pedro-med-stat-7" </p></div><p><b>status</b>: active</p><p><b>medication</b>: See on this page: Medication/6f4151e9-91f6-4f1e-adc3-fb94dda77857: Protein supplements</p><p><b>subject</b>: See on this page: Patient/pedro-patient: Pedro Gravitate</p><h3>Dosages</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Route</b></td></tr><tr><td style=\"display: none\">*</td><td>Oral use <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (standardterms.edqm.eu#20053000)</span></td></tr></table></div>"
},
"status" : "active",
"medicationReference" : {
"reference" : "Medication/6f4151e9-91f6-4f1e-adc3-fb94dda77857",
"display" : "Protein supplements"
},
"subject" : {
"reference" : "Patient/pedro-patient",
"display" : "Pedro Gravitate"
},
"dosage" : [
{
"route" : {
"coding" : [
{
"system" : "http://standardterms.edqm.eu",
"code" : "20053000",
"display" : "Oral use"
}
]
}
}
]
}
},
{
"fullUrl" : "https://myserver.org/Medication/9d7be868-8264-4d94-ad04-ef04ecc92e52",
"resource" : {
"resourceType" : "Medication",
"id" : "9d7be868-8264-4d94-ad04-ef04ecc92e52",
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><a name=\"Medication_9d7be868-8264-4d94-ad04-ef04ecc92e52\"> </a><p><b>Generated Narrative: Medication</b><a name=\"9d7be868-8264-4d94-ad04-ef04ecc92e52\"> </a><a name=\"hc9d7be868-8264-4d94-ad04-ef04ecc92e52\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">ResourceMedication "9d7be868-8264-4d94-ad04-ef04ecc92e52" </p></div><p><b>code</b>: Dovato 50 mg/300 mg 30 tablets <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (pmswi#EU/1/19/1370/001; phpid#0x073AF2E5B92AE19E8B67635AFFB3D6CA "lamivudine and dolutegravir, 300 mg/50 mg, tablets"; <a href=\"https://browser.ihtsdotools.org/\">SNOWMED CT</a>#787165000 "Dolutegravir- and lamivudine-containing product in oral dose form"; <a href=\"http://terminology.hl7.org/5.5.0/CodeSystem-v3-WC.html\">WHO ATC</a>#J05AR25 "lamivudine and dolutegravir")</span></p><p><b>form</b>: Coated tablet <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (standardterms.edqm.eu#10220000)</span></p><blockquote><p><b>ingredient</b></p><p><b>item</b>: lamivudine <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://terminology.hl7.org/5.5.0/CodeSystem-UNII.html\">Unique Ingredient Identifier (UNII)</a>#2T8Q726O95)</span></p><p><b>strength</b>: 300 mg<span style=\"background: LightGoldenRodYellow\"> (Details: UCUM code mg = 'mg')</span>/1 Tablet<span style=\"background: LightGoldenRodYellow\"> (Details: standardterms.edqm.eu code 15054000 = 'Tablet')</span></p></blockquote><blockquote><p><b>ingredient</b></p><p><b>item</b>: dolutegravir <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://terminology.hl7.org/5.5.0/CodeSystem-UNII.html\">Unique Ingredient Identifier (UNII)</a>#DKO1W9H7M1)</span></p><p><b>strength</b>: 50 mg<span style=\"background: LightGoldenRodYellow\"> (Details: UCUM code mg = 'mg')</span>/1 Tablet<span style=\"background: LightGoldenRodYellow\"> (Details: standardterms.edqm.eu code 15054000 = 'Tablet')</span></p></blockquote></div>"
},
"code" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/pmswi",
"code" : "EU/1/19/1370/001",
"display" : "Dovato 50 mg/300 mg 30 tablets"
},
{
"system" : "https://www.who-umc.org/phpid",
"code" : "0x073AF2E5B92AE19E8B67635AFFB3D6CA",
"display" : "lamivudine and dolutegravir, 300 mg/50 mg, tablets"
},
{
"system" : "http://snomed.info/sct",
"code" : "787165000",
"display" : "Dolutegravir- and lamivudine-containing product in oral dose form"
},
{
"system" : "http://www.whocc.no/atc",
"code" : "J05AR25",
"display" : "lamivudine and dolutegravir"
}
]
},
"form" : {
"coding" : [
{
"system" : "http://standardterms.edqm.eu",
"code" : "10220000",
"display" : "Coated tablet"
}
]
},
"ingredient" : [
{
"itemCodeableConcept" : {
"coding" : [
{
"system" : "http://fdasis.nlm.nih.gov",
"code" : "2T8Q726O95",
"display" : "lamivudine"
}
],
"text" : "lamivudine"
},
"strength" : {
"numerator" : {
"value" : 300,
"system" : "http://unitsofmeasure.org",
"code" : "mg"
},
"denominator" : {
"value" : 1,
"unit" : "Tablet",
"system" : "http://standardterms.edqm.eu",
"code" : "15054000"
}
}
},
{
"itemCodeableConcept" : {
"coding" : [
{
"system" : "http://fdasis.nlm.nih.gov",
"code" : "DKO1W9H7M1",
"display" : "dolutegravir"
}
],
"text" : "dolutegravir"
},
"strength" : {
"numerator" : {
"value" : 50,
"system" : "http://unitsofmeasure.org",
"code" : "mg"
},
"denominator" : {
"value" : 1,
"unit" : "Tablet",
"system" : "http://standardterms.edqm.eu",
"code" : "15054000"
}
}
}
]
}
},
{
"fullUrl" : "https://myserver.org/Medication/fdb5c97f-0a46-41ba-bc34-2efd2ef2f7e4",
"resource" : {
"resourceType" : "Medication",
"id" : "fdb5c97f-0a46-41ba-bc34-2efd2ef2f7e4",
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><a name=\"Medication_fdb5c97f-0a46-41ba-bc34-2efd2ef2f7e4\"> </a><p><b>Generated Narrative: Medication</b><a name=\"fdb5c97f-0a46-41ba-bc34-2efd2ef2f7e4\"> </a><a name=\"hcfdb5c97f-0a46-41ba-bc34-2efd2ef2f7e4\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">ResourceMedication "fdb5c97f-0a46-41ba-bc34-2efd2ef2f7e4" </p></div><p><b>code</b>: MIRTAZAPINA CINFA 30 mg Coated Tablet <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (pmswi#67.068; phpid#0x6c47381b040e5b588db23b2272f28eec "mirtazapine 30 mg, tablets"; <a href=\"http://terminology.hl7.org/5.5.0/CodeSystem-v3-WC.html\">WHO ATC</a>#N06AX11 "mirtazapine")</span></p><p><b>form</b>: Coated tablet <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (standardterms.edqm.eu#10220000)</span></p><h3>Ingredients</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Item[x]</b></td><td><b>Strength</b></td></tr><tr><td style=\"display: none\">*</td><td>Mirtazapine <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://terminology.hl7.org/5.5.0/CodeSystem-UNII.html\">Unique Ingredient Identifier (UNII)</a>#A051Q2099Q)</span></td><td>30 g<span style=\"background: LightGoldenRodYellow\"> (Details: UCUM code g = 'g')</span>/1 Tablet<span style=\"background: LightGoldenRodYellow\"> (Details: standardterms.edqm.eu code 15054000 = 'Tablet')</span></td></tr></table></div>"
},
"code" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/pmswi",
"code" : "67.068",
"display" : "MIRTAZAPINA CINFA 30 mg Coated Tablet"
},
{
"system" : "https://www.who-umc.org/phpid",
"code" : "0x6c47381b040e5b588db23b2272f28eec",
"display" : "mirtazapine 30 mg, tablets"
},
{
"system" : "http://www.whocc.no/atc",
"code" : "N06AX11",
"display" : "mirtazapine"
}
]
},
"form" : {
"coding" : [
{
"system" : "http://standardterms.edqm.eu",
"code" : "10220000",
"display" : "Coated tablet"
}
]
},
"ingredient" : [
{
"itemCodeableConcept" : {
"coding" : [
{
"system" : "http://fdasis.nlm.nih.gov",
"code" : "A051Q2099Q",
"display" : "Mirtazapine"
}
],
"text" : "Mirtazapine"
},
"strength" : {
"numerator" : {
"value" : 30,
"system" : "http://unitsofmeasure.org",
"code" : "g"
},
"denominator" : {
"value" : 1,
"unit" : "Tablet",
"system" : "http://standardterms.edqm.eu",
"code" : "15054000"
}
}
}
]
}
},
{
"fullUrl" : "https://myserver.org/Medication/6f4151e9-91f6-4f1e-adc3-fb94dda7785g",
"resource" : {
"resourceType" : "Medication",
"id" : "6f4151e9-91f6-4f1e-adc3-fb94dda7785g",
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><a name=\"Medication_6f4151e9-91f6-4f1e-adc3-fb94dda7785g\"> </a><p><b>Generated Narrative: Medication</b><a name=\"6f4151e9-91f6-4f1e-adc3-fb94dda7785g\"> </a><a name=\"hc6f4151e9-91f6-4f1e-adc3-fb94dda7785g\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">ResourceMedication "6f4151e9-91f6-4f1e-adc3-fb94dda7785g" </p></div><p><b>code</b>: CALCIO/VITAMINA D3 ROVI 1000 mg/880 UI COMPRIMIDOS EFERVESCENTES <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (pmswi#68290; phpid#0xF79CABF272B6A7EEF104DDDA44E82716 "Calcium Vitamin D")</span></p><p><b>form</b>: Effervescent tablet <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (standardterms.edqm.eu#10222000)</span></p><blockquote><p><b>ingredient</b></p><p><b>item</b>: calcium carbonate <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://terminology.hl7.org/5.5.0/CodeSystem-UNII.html\">Unique Ingredient Identifier (UNII)</a>#H0G9379FGK "Calcium carbonate")</span></p><p><b>strength</b>: 1000 mg<span style=\"background: LightGoldenRodYellow\"> (Details: UCUM code mg = 'mg')</span>/1 Tablet<span style=\"background: LightGoldenRodYellow\"> (Details: standardterms.edqm.eu code 15054000 = 'Tablet')</span></p></blockquote><blockquote><p><b>ingredient</b></p><p><b>item</b>: cholecalciferol <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://terminology.hl7.org/5.5.0/CodeSystem-UNII.html\">Unique Ingredient Identifier (UNII)</a>#1C6V77QF41)</span></p><p><b>strength</b>: 880 {UI}<span style=\"background: LightGoldenRodYellow\"> (Details: UCUM code {UI} = '{UI}')</span>/1 Tablet<span style=\"background: LightGoldenRodYellow\"> (Details: standardterms.edqm.eu code 15054000 = 'Tablet')</span></p></blockquote></div>"
},
"code" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/pmswi",
"code" : "68290",
"display" : "CALCIO/VITAMINA D3 ROVI 1000 mg/880 UI COMPRIMIDOS EFERVESCENTES"
},
{
"system" : "https://www.who-umc.org/phpid",
"code" : "0xF79CABF272B6A7EEF104DDDA44E82716",
"display" : "Calcium Vitamin D"
}
]
},
"form" : {
"coding" : [
{
"system" : "http://standardterms.edqm.eu",
"code" : "10222000",
"display" : "Effervescent tablet"
}
],
"text" : "Effervescent tablet"
},
"ingredient" : [
{
"itemCodeableConcept" : {
"coding" : [
{
"system" : "http://fdasis.nlm.nih.gov",
"code" : "H0G9379FGK",
"display" : "Calcium carbonate"
}
],
"text" : "calcium carbonate"
},
"strength" : {
"numerator" : {
"value" : 1000,
"system" : "http://unitsofmeasure.org",
"code" : "mg"
},
"denominator" : {
"value" : 1,
"unit" : "Tablet",
"system" : "http://standardterms.edqm.eu",
"code" : "15054000"
}
}
},
{
"itemCodeableConcept" : {
"coding" : [
{
"system" : "http://fdasis.nlm.nih.gov",
"code" : "1C6V77QF41",
"display" : "cholecalciferol"
}
],
"text" : "cholecalciferol"
},
"strength" : {
"numerator" : {
"value" : 880,
"system" : "http://unitsofmeasure.org",
"code" : "{UI}"
},
"denominator" : {
"value" : 1,
"unit" : "Tablet",
"system" : "http://standardterms.edqm.eu",
"code" : "15054000"
}
}
}
]
}
},
{
"fullUrl" : "https://myserver.org/Medication/6f4151e9-91f6-4f1e-adc3-fb94dda77854",
"resource" : {
"resourceType" : "Medication",
"id" : "6f4151e9-91f6-4f1e-adc3-fb94dda77854",
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><a name=\"Medication_6f4151e9-91f6-4f1e-adc3-fb94dda77854\"> </a><p><b>Generated Narrative: Medication</b><a name=\"6f4151e9-91f6-4f1e-adc3-fb94dda77854\"> </a><a name=\"hc6f4151e9-91f6-4f1e-adc3-fb94dda77854\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">ResourceMedication "6f4151e9-91f6-4f1e-adc3-fb94dda77854" </p></div><p><b>code</b>: BLASTON 1 mg tablets <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (pmswi#59.032; phpid#0xbb82cd10ab2add752b2b9224931077b2 "cinitrapide 1 mg tablet"; <a href=\"http://terminology.hl7.org/5.5.0/CodeSystem-v3-WC.html\">WHO ATC</a>#A03FA08 "Cinitapride")</span></p><p><b>form</b>: Tablet <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (standardterms.edqm.eu#10219000)</span></p><h3>Ingredients</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Item[x]</b></td><td><b>Strength</b></td></tr><tr><td style=\"display: none\">*</td><td>CINITAPRIDE <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://terminology.hl7.org/5.5.0/CodeSystem-UNII.html\">Unique Ingredient Identifier (UNII)</a>#R8I97I2L24)</span></td><td>1 mg<span style=\"background: LightGoldenRodYellow\"> (Details: UCUM code mg = 'mg')</span>/1 Tablet<span style=\"background: LightGoldenRodYellow\"> (Details: standardterms.edqm.eu code 15054000 = 'Tablet')</span></td></tr></table></div>"
},
"code" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/pmswi",
"code" : "59.032",
"display" : "BLASTON 1 mg tablets"
},
{
"system" : "https://www.who-umc.org/phpid",
"code" : "0xbb82cd10ab2add752b2b9224931077b2",
"display" : "cinitrapide 1 mg tablet"
},
{
"system" : "http://www.whocc.no/atc",
"code" : "A03FA08",
"display" : "Cinitapride"
}
]
},
"form" : {
"coding" : [
{
"system" : "http://standardterms.edqm.eu",
"code" : "10219000",
"display" : "Tablet"
}
],
"text" : "Tablet"
},
"ingredient" : [
{
"itemCodeableConcept" : {
"coding" : [
{
"system" : "http://fdasis.nlm.nih.gov",
"code" : "R8I97I2L24",
"display" : "CINITAPRIDE"
}
],
"text" : "CINITAPRIDE"
},
"strength" : {
"numerator" : {
"value" : 1,
"system" : "http://unitsofmeasure.org",
"code" : "mg"
},
"denominator" : {
"value" : 1,
"unit" : "Tablet",
"system" : "http://standardterms.edqm.eu",
"code" : "15054000"
}
}
}
]
}
},
{
"fullUrl" : "https://myserver.org/Medication/6f4151e9-91f6-4f1e-adc3-fb94dda77855",
"resource" : {
"resourceType" : "Medication",
"id" : "6f4151e9-91f6-4f1e-adc3-fb94dda77855",
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><a name=\"Medication_6f4151e9-91f6-4f1e-adc3-fb94dda77855\"> </a><p><b>Generated Narrative: Medication</b><a name=\"6f4151e9-91f6-4f1e-adc3-fb94dda77855\"> </a><a name=\"hc6f4151e9-91f6-4f1e-adc3-fb94dda77855\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">ResourceMedication "6f4151e9-91f6-4f1e-adc3-fb94dda77855" </p></div><p><b>code</b>: AQUILEA ARTICULACIONES COLAGENO Y MAGNESIO 375GR <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (pmswi#0xb9846396e9e1eedc4a344e7b64d57107)</span></p><p><b>form</b>: Oral powder <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (standardterms.edqm.eu#10201000)</span></p><blockquote><p><b>ingredient</b></p><p><b>item</b>: MAGNESIUM <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://terminology.hl7.org/5.5.0/CodeSystem-UNII.html\">Unique Ingredient Identifier (UNII)</a>#I38ZP9992A)</span></p></blockquote><blockquote><p><b>ingredient</b></p><p><b>item</b>: HYALURONIC ACID <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://terminology.hl7.org/5.5.0/CodeSystem-UNII.html\">Unique Ingredient Identifier (UNII)</a>#S270N0TRQY)</span></p></blockquote><blockquote><p><b>ingredient</b></p><p><b>item</b>: HUMAN TYPE I COLLAGEN <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://terminology.hl7.org/5.5.0/CodeSystem-UNII.html\">Unique Ingredient Identifier (UNII)</a>#PT3TGI7OIP)</span></p></blockquote></div>"
},
"code" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/pmswi",
"code" : "0xb9846396e9e1eedc4a344e7b64d57107",
"display" : "AQUILEA ARTICULACIONES COLAGENO Y MAGNESIO 375GR"
}
]
},
"form" : {
"coding" : [
{
"system" : "http://standardterms.edqm.eu",
"code" : "10201000",
"display" : "Oral powder"
}
],
"text" : "Oral powder"
},
"ingredient" : [
{
"itemCodeableConcept" : {
"coding" : [
{
"system" : "http://fdasis.nlm.nih.gov",
"code" : "I38ZP9992A",
"display" : "MAGNESIUM"
}
],
"text" : "MAGNESIUM"
}
},
{
"itemCodeableConcept" : {
"coding" : [
{
"system" : "http://fdasis.nlm.nih.gov",
"code" : "S270N0TRQY",
"display" : "HYALURONIC ACID"
}
],
"text" : "HYALURONIC ACID"
}
},
{
"itemCodeableConcept" : {
"coding" : [
{
"system" : "http://fdasis.nlm.nih.gov",
"code" : "PT3TGI7OIP",
"display" : "HUMAN TYPE I COLLAGEN"
}
],
"text" : "HUMAN TYPE I COLLAGEN"
}
}
]
}
},
{
"fullUrl" : "https://myserver.org/Medication/6f4151e9-91f6-4f1e-adc3-fb94dda77856",
"resource" : {
"resourceType" : "Medication",
"id" : "6f4151e9-91f6-4f1e-adc3-fb94dda77856",
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><a name=\"Medication_6f4151e9-91f6-4f1e-adc3-fb94dda77856\"> </a><p><b>Generated Narrative: Medication</b><a name=\"6f4151e9-91f6-4f1e-adc3-fb94dda77856\"> </a><a name=\"hc6f4151e9-91f6-4f1e-adc3-fb94dda77856\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">ResourceMedication "6f4151e9-91f6-4f1e-adc3-fb94dda77856" </p></div><p><b>code</b>: SORIA NATURAL VITAMINA C 36 COMPRIMIDOS <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (pmswi#0x173fdc0ef097ed4dbe3915fba2e90586; <a href=\"http://terminology.hl7.org/5.5.0/CodeSystem-v3-WC.html\">WHO ATC</a>#A11GA01 "ascorbic acid (vit C)")</span></p><p><b>form</b>: Modified-release tablet <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (standardterms.edqm.eu#10227000)</span></p><h3>Ingredients</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Item[x]</b></td></tr><tr><td style=\"display: none\">*</td><td>Vitamin C <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://terminology.hl7.org/5.5.0/CodeSystem-UNII.html\">Unique Ingredient Identifier (UNII)</a>#PQ6CK8PD0R "ASCORBIC ACID")</span></td></tr></table></div>"
},
"code" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/pmswi",
"code" : "0x173fdc0ef097ed4dbe3915fba2e90586",
"display" : "SORIA NATURAL VITAMINA C 36 COMPRIMIDOS"
},
{
"system" : "http://www.whocc.no/atc",
"code" : "A11GA01",
"display" : "ascorbic acid (vit C)"
}
]
},
"form" : {
"coding" : [
{
"system" : "http://standardterms.edqm.eu",
"code" : "10227000",
"display" : "Modified-release tablet"
}
],
"text" : "Modified-release tablet"
},
"ingredient" : [
{
"itemCodeableConcept" : {
"coding" : [
{
"system" : "http://fdasis.nlm.nih.gov",
"code" : "PQ6CK8PD0R",
"display" : "ASCORBIC ACID"
}
],
"text" : "Vitamin C"
}
}
]
}
},
{
"fullUrl" : "https://myserver.org/Medication/6f4151e9-91f6-4f1e-adc3-fb94dda77857",
"resource" : {
"resourceType" : "Medication",
"id" : "6f4151e9-91f6-4f1e-adc3-fb94dda77857",
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><a name=\"Medication_6f4151e9-91f6-4f1e-adc3-fb94dda77857\"> </a><p><b>Generated Narrative: Medication</b><a name=\"6f4151e9-91f6-4f1e-adc3-fb94dda77857\"> </a><a name=\"hc6f4151e9-91f6-4f1e-adc3-fb94dda77857\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">ResourceMedication "6f4151e9-91f6-4f1e-adc3-fb94dda77857" </p></div><p><b>code</b>: NATURES PLUS SPIRU-TEIN BATIDO PROTEINA SABOR COOKIES 525GR <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (pmswi#0x81bb4f17d1ea7aabcd39383d33a4f2d6)</span></p><p><b>form</b>: Oral powder <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (standardterms.edqm.eu#10201000)</span></p><h3>Ingredients</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Item[x]</b></td></tr><tr><td style=\"display: none\">*</td><td>SOY PROTEIN <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://terminology.hl7.org/5.5.0/CodeSystem-UNII.html\">Unique Ingredient Identifier (UNII)</a>#R44IWB3RN5)</span></td></tr></table></div>"
},
"code" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/pmswi",
"code" : "0x81bb4f17d1ea7aabcd39383d33a4f2d6",
"display" : "NATURES PLUS SPIRU-TEIN BATIDO PROTEINA SABOR COOKIES 525GR"
}
]
},
"form" : {
"coding" : [
{
"system" : "http://standardterms.edqm.eu",
"code" : "10201000",
"display" : "Oral powder"
}
],
"text" : "Oral powder"
},
"ingredient" : [
{
"itemCodeableConcept" : {
"coding" : [
{
"system" : "http://fdasis.nlm.nih.gov",
"code" : "R44IWB3RN5",
"display" : "SOY PROTEIN"
}
],
"text" : "SOY PROTEIN"
}
}
]
}
}
]
}
IG © 2021+ . Package hl7.eu.fhir.gh-ips#0.1.0 based on FHIR 4.0.1. Generated 2024-05-14
Links: Table of Contents |
QA Report
The Gravitate Health project has received funding from the IMI 2 Joint Undertaking under grant agreement No 945334.
This joint undertaking receives support from the EU H2020 research and innovation programme and EFPIA.
